Navigation Links
Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive

Researchers see hopes in a new therapy combining low dose steroid with lenalidomide, already// found effective against multiple myeloma.

Multiple myeloma is a cancer of plasma cells that are found in blood and bone marrow.

Survival chances improved considerably when a low dose of the steroid dexamethasone combined with lenalidomide was tried on patients with newly diagnosed multiple myeloma.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG).

The significance of the results lies in that a low dose regimen has been found to be more effective than the standard dose of dexamethasone.

Researchers found that patients in the study who received a lower dose regimen had a one-year survival of 96 percent compared to 86 per cent for patients treated in the case of those with the standard-dose of dexamethasone and lenalidomide.

In addition, there were fewer side effects associated with the low-dose dexamethasone and lenalidomide.

"These results have major implications for myeloma therapy," noted study chair Vincent Rajkumar. "The results of this study, particularly lenalidomide plus low-dose dexamethasone, are very positive and in my opinion represent a real step forward in the treatment of this disease."

The application of this effective and less toxic approach is expected to benefit many patients with myeloma.

In 2007, an estimated 19,900 people in the United States will be diagnosed with multiple myeloma and an estimated 10,790 people will die of the disease.
SRM
'"/>




Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
(Date:9/19/2014)... One of the major trends in the market ... useful in different application sectors such as hard tissue ... forecast the Global Bioactive Material Market to ... period 2013-2018. According to the report, increase in aging ... market. There will be an increased number of trauma, ...
(Date:9/19/2014)... Mount Pleasant Retirement Village has partnered ... Well-Being Coach Christi Hall to campus. , Hall’s journey to ... and gaining weight as a result of years of medication. ... about nutrition. One year later she had lost 50 pounds, ... endurance and cardio. , After joining the YMCA staff, she ...
(Date:9/19/2014)... There are thousands of older women who ... and there are thousands of younger men who would love ... SeekingCougar.com now provides the world's best collection of resources ... older women, and the younger men who would like to ... these people to meet each other and establish those romantic ...
(Date:9/18/2014)... Thompson and Mathieu Nikel decided it was time to tie the ... Isaac, said there was only one choice for them – Mercy ... Thompson was an undergraduate student and needed a French tutor. She ... French and so she asked him. , Thompson is ... was 7 years old. Nikel is originally from France came ...
(Date:9/18/2014)... Dr. David A. F. Ellis is a ... of Facial Plastic and Reconstructive Surgery and a Professor ... Facial Plastic Surgery. He is recognized around the ... , Dr. Ellis will be presenting on numerous injectable ... injection techniques and various treatments for complications associated with ...
Breaking Medicine News(10 mins):Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 3Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 4Health News:Mount Pleasant Retirement Village Partners with Atrium Family YMCA 2Health News:Mount Pleasant Retirement Village Partners with Atrium Family YMCA 3Health News:Dating Site "SeekingCougar.com" Now Offering Tips for Younger Men Seeking Older Women 2Health News:For The First Time in Over a Decade Mercy College Alumni Marry at College 2Health News:Dr. David A. F. Ellis Has Been Invited to Speak at a Conference of the American Academy of Facial Plastic and Reconstructive Surgery in Orlando, Florida 2
... Oct. 17 Symmetry Medical Inc.,(NYSE: SMA ... global orthopedic,device industry and other medical markets, announced ... Officer, Europe effective November 1,2007. Mr. Hynes ... case facilities across Europe including the UK, Ireland,France ...
... against the facial paralysis, study finds , , WEDNESDAY, Oct. 17 ... at easing a form of facial paralysis called Bell,s palsy ... that acyclovir may not be a new, improved treatment option ... the other hand, many people afflicted with Bell,s palsy do ...
... receive failing grades , , WEDNESDAY, Oct. 17 (HealthDay News) -- ... to women,s health, a new report contends. , The report ... meets only three of 27 benchmarks for women,s health. Those ... who get regular mammograms; the percentage of women who visit ...
... Include New Research on HIV Screening, Pandemic Flu,Neonatal ... WASHINGTON, Oct. 17 More than 13,000 public,health ... to address the,nation,s top public health challenges at ... The conference will feature leading experts, researchers ...
... Oct. 17 Two health care leaders were,presented ... (MHA),Health Care Leadership Award. Terence F. Moore, president ... the award in the,category of hospital management and ... with the award in the category of patient ...
... Lumenos suite of products helps consumers manage costs and adopt healthier ... ... Anthem Blue Cross and Blue,Shield in Virginia is now offering new health ... about health,care-helping them to lead healthier lives and gain control over the ...
Cached Medicine News:Health News:Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe 2Health News:Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe 3Health News:Antiviral Won't Improve Bell's Palsy Outcome 2Health News:U.S. Women's Health Care Still Falls Short: Report 2Health News:U.S. Women's Health Care Still Falls Short: Report 3Health News:Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting, Nov. 3-7 2Health News:Association Honors Health Care Leaders in Midland and Troy 2Health News:Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products 2Health News:Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products 3Health News:Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products 4
(Date:9/19/2014)... Aufgrund der enormen Nachfrage ... Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die Jahre 2014 ... pharmaserialisation.com , zeigt die Serialisierungsanforderungen weltweit und ... treten. Für international tätige Unternehmen geht ... "ob", sondern darum, "wann" sie die neu in ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners ... Future to Benefit the Radiation Oncology Institute (ROI), hosted ... at Golden Gate Park in San Francisco.  ... Moore , CEO of Radiation Business Solutions, "but ... have raised over $70,000 for the ROI this year. ...
(Date:9/19/2014)... -- Intarcia Therapeutics, Inc. today announced the ... candidate ITCA 650 (continuous subcutaneous delivery of exenatide) in ... at the 50 th Annual Meeting of the ... from the open-label, phase 3 FREEDOM-HBL (high baseline) trial ... with poorly controlled type 2 diabetes. The results were ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... Sept. 20 Cellectis bioresearch, the specialist in ... and Helix BioService & Consultants Pvt Ltd (Helix ... for the promotion of Cellectis bioresearch,s meganuclease-based products ... young company comprised of professionals with proven expertise ...
... JOSE, Calif., Sept. 17 Teikoku Pharma USA, Inc., ... U.S. Food and Drug Administration (FDA) has accepted for ... weekly transdermal patch of Aricept®, a leading medication for ... developed the weekly Aricept(r) patch based on a license ...
Cached Medicine Technology:Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India 2Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India 3FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review 2
... The Infinity AST (GOT) powder reagent ... convenience of single liquid stability to help ... provide quick result turnaround time. The patented ... reagent provides a long shelf life and ...
LCD chart display...
... are extremely delicate and if repairs are ... can easily be damaged beyond repair and ... , On the other hand, with conscientious ... have a virtually indefinite lifespan. The very ...
Mobile offers full life cycle service for Sp02 accessories that are the vital link between pulse oximeter and patient...
Medicine Products: